Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia
Robert W. Schrier(University of Denver), Cesare Orlandi(University of Rochester Medical Center)
Cited by 1,208
Related Papers
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2015|602
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction
|Journal of the American College of Cardiology|1999|541
Hypertonicity-induced Aquaporin-1 (AQP1) Expression Is Mediated by the Activation of MAPK Pathways and Hypertonicity-responsive Element in the AQP1 Gene
|Journal of Biological Chemistry|2003|163
Abstracts
|Blood Purification|2009|0